Structural Nested Mean Models (SNMMs) are useful for causal inference of treatment effects in longitudinal observational studies, accounting for time-varying confounding. Most of existing estimation of SNMMs assumes that the data are collected at finite, discrete, and pre-fixed time points for all subjects. However, the variables and processes are likely to be observed at irregularly-spaced time points in practice, and it is more realistic to assume that the data are generated from continuous-time processes. We establish the semiparametric efficiency theory for continuous-time SNMMs with irregularly-spaced observations under a martingale condition of no unmeasured confounding. We construct locally efficient estimators of the causal effect parameters, which achieve the semiparametric efficiency bound. In the presence of dependent censoring, we propose an inverse probability of censoring weighted estimator. The resulting estimator is doubly robust, in the sense that if either the model for the treatment process is correctly specified or the potential outcome mean model is correctly specified, but not necessarily both. We establish the asymptotic distribution of the proposed estimator, which allows for doubly robust inference. Simulation studies demonstrate that the proposed estimator is superior to the current competitors in finite samples. We apply the proposed estimator to estimate the effect of the effect of highly active antiretroviral therapy on the CD4 count at year 2 in HIVpositive patients with early and acute infection.
Introduction
The gold standard to draw causal inference of treatment effects is designing randomized experiments. However, randomized experiments are not always feasible due to practical constraints or ethical issues. Moreover, randomized experiments often have restrictive inclusion and exclusion criteria for patient enrollment, which limits the experiment results to be generalized to a larger realworld patient population. In these cases, observational data are useful. In observational studies, confounding by indication poses a unique challenge to drawing valid causal inference of treatment effects. For example, sicker patients are more likely to take the active treatment, whereas healthier patients are more likely to take the control treatment. Consequently, it is not fair to compare the outcome from the treatment group and the control group directly. Moreover, in longitudinal observational studies, confounding by indication is likely to be time-dependent, in the sense that time-varying prognostic factors of the outcome affect the treatment assignment at each time, and thereby distort the association between treatment and outcome over time. In these cases, the traditional regression methods are biased even adjusting for the time-varying confounders 1992; 2000 Robins and Hernán; 2009; Orellana et al.; .
Structural Nested Mean Models (SNMMs) and g-estimation have been proposed by Robins (1994) to overcome the challenges with time-varying confounding to draw causal inference of treatment effects from longitudinal observational studies. The literature thereafter is fruitful; see, e.g., Robins (1998b) , Robins (2000) , Robins et al. (2000) , Almirall et al. (2010) , Chakraborty and Moodie (2013) , Lok and DeGruttola (2012) , Lok and Griner (2014) , Yang and Lok (2016) , Yang and Lok (2017) , and Hernan and Robins (2018) . Vansteelandt et al. (2014) provided a comprehensive overview on this topic. Most of the existing work on the SNMMs and g-estimation assume discrete-time data generating processes and require all subjects to be followed at the same pre-fixed time points. However, the observational data are often collected by user-initiated visits to clinics, hospitals and pharmacies in practice, and the data are more likely to be measured at irregularly-spaced time points, which are not necessarily the same for all subjects. Such data are now commonplace, such as electronic health records, claims databases, disease data registries, and so on (Chatterjee et al.; 2016) . The existing framework of SNMMs does not directly apply in such situations, requiring some (possibly arbitrary) discretization of the timeline (Neugebauer et al.; . Such data preprocessing is quite standard and routine to practitioners, but leads to many unresolved problems: the treatment process depends transparently on the discretization, and therefore the interpretation of SNMMs depends on the definition of time interval 1998a) . Moreover, after discretization, data are either averaged or imputed at all time points. The resulting data may not satisfy the standard consistency or no unmeasured confounding assumptions. Consequently, model parameters may not have a causal interpretation.
It is more reasonable to assume that the data are generated from continuous-time processes. The work for causal models in continuous-time processes is somewhat sparse; exceptions include e.g. Robins (1998a) ; Lok et al. (2004) ; Lok (2008) ; Zhang et al. (2011) . Extending the existing causal models with discrete-time processes to continuous-time processes is not trivial, even for the classical assumption of no unmeasured confounding. In the discrete-time setting, this assumption is formalized as the conditional independence of the potential outcomes and the treatment assignment given the past covariate history at each time point. A practical implication is that the covariate set should be rich enough to include all predictors of outcome and treatment, so that we can distinguish the treatment effect and the confounding effect. In the continuous-time setting, as pointed out by Lok (2008) , the above formalization of no unmeasured confounding is not accurate, because it results in the conditional independence of the potential outcomes and null events given null events at a continuous time t. Lok (2008) provided a new formalization in terms of a martingale condition when the treatment process is viewed as a counting process. This definition was also adopted in Zhang et al. (2011) to the setting where the effect of a treatment varies in continuous time and the time-dependent confounders are observed only at discrete times. Lok (2017) provided a strategy of constructing unbiased estimating equations exploiting the relationship between the mimicking potential outcome process and the treatment process, which leads to a large class of estimators. While this estimating strategy can provide unbiased estimators, there is no guidance on how to choose an efficient estimator, and a naive choice can lead to inaccurate estimation and therefore a less useful inference.
In this article, we develop efficient estimators of continuous-time SNMMs with irregularly-spaced observations. Toward that end, we take the geometric approach of Bickel et al. (1993) to establish the semiparametric efficiency theory for continuous-time SNMMs under the martingale condition for no unmeasured confounding of Lok (2008) . The semiparametric efficiency theory allows us to construct locally efficient estimators of the SNMM parameters which achieve the semiparametric efficiency bound. To accommodate possible dependent censoring, we propose the inverse probability of censoring weighting (IPCW) estimator. We show that the proposed estimator is doubly robust, in the sense that it achieves the consistency if either the model for the treatment process is correctly specified or the potential outcome mean model is correctly specified, but not necessarily both. Moreover, we characterize the asymptotic distribution of the proposed estimator if either model component is correctly specified allowing for doubly robust inference. In contrast to the existing gestimators that needs data pre-processing, the new estimation framework respects the nature of the underlying data generating mechanism and allows us to deal with irregularly-spaced observations directly. We also demonstrate the danger of such pre-processing that may introduce bias into estimation via simulation.
The rest of the article is organized as follows. In Section 2, we describe the SNMMs with discretetime processes, which serves as a building block to establishing the semiparametric efficiency theory for continuous-time processes and also enables us to see their connection. In Section 3, we present the semiparametric efficiency theory and efficient estimators for continuous-time SNMMs under the no unmeasured confounding assumption. In Section 3.4, we propose an IPCW estimator to deal with dependent censoring due to premature drop out. In Section 4, we establish the asymptotic distribution of the estimator allowing for double robust inference. In Section 5, we present simulation studies to investigate the performance of the proposed estimator compared to the existing competitors in finite samples. In Section 6, we applied the proposed estimator to estimate the effect of the time between HIV infection and initiation of highly active antiretroviral therapy (HAART) on the CD4 count at year 2 after infection in HIV-positive patients with early and acute infection. We conclude the article with discussions in Section 7.
2 Structural nested mean models in discrete-time processes
Setup, models, and assumptions
We first describe SNMMs in discrete-time processes. We assume that n subjects are followed at pre-fixed discrete times t 0 < · · · < t K+1 with t 0 = 0 and t K+1 = τ . We assume that the subjects are an independent sample from a larger population 1978) . For simplicity, we suppress the subscript i for subjects. Let L m be a vector of covariates at time t m . Let A m be the treatment indicator at time t m ; i.e., A m = 1 if the subject was on treatment at t m and A m = 0 otherwise. We use the overline notation to denote a variable's history; e.g., A m = (A t 0 , . . . , A tm ). We assume that once treatment is initiated, it is never discontinued, so each treatment regime corresponds to one treatment initiation time. Let T be the time to treatment initiation, and let T = ∞ if the subject never initiated the treatment during the follow up. Let Γ be the indicator that the treatment initiation time is less than τ ; i.e., Γ = 1 if the subject initiated the treatment before τ and Γ = 0 otherwise. Let Y (m) be the potential outcome at the end of study τ , had the subject initiated the treatment at time t m , and let Y (∞) be the potential outcome at the end of study τ had the subject never initiated the treatment during the study follow up. Let V m = (A m−1 , L m ) be the vector of treatment and covariate. Let Y be the continuous outcome measured at the end of the study τ . Finally, the subject's full record is F = (A K , L K , Y ).
Following Lok and DeGruttola (2012) , the discrete-time SNMM for the treatment effect is as follows.
i.e., γ m (L m ; ψ) with ψ ∈R p is a correctly specified model for γ m (L m ) with the true parameter value ψ * .
This model specifies the conditional expectation of the treatment contrasts Y (m) − Y (∞) , given subject's observed covariates history L m . Intuitively, it states that the conditional mean of the outcome is shifted by γ m (L m ; ψ * ) had the subject initiated the treatment at time t m comparing to never starting. Therefore, the parameter ψ * has a causal interpretation. To help understand the model, we consider
. This model entails that on average, the treatment would increase the mean of the outcome had the subject initiated the treatment at time t m by (ψ * 1 + ψ * 2 t m )(τ − t m ), and the magnitude of the increase depends on the duration of the treatment and the treatment initiation time. If ψ * 1 + ψ * 2 t m > 0 and ψ * 2 < 0, it indicates the treatment is beneficial and earlier initiation is better.
We make the consistency assumption to link the observed data to the potential outcomes.
Assumption 2 (Consistency) The observed outcome is equal to the potential outcome under the actual treatment received; i.e., Y = Y (T ) .
If all potential outcomes were observed for each subject, we can directly compare these outcomes to infer the treatment effect; however, the fundamental problem in causal inference is that we can not observe all potential outcomes for a particular subject (Holland; 1986) . In particular, we can observe Y (∞) only for the subjects who did not initiate the treatment during the follow up. To overcome this issue, we define
Intuitively, H(ψ * ) subtracts the treatment effect γ T (L T ; ψ * ) from the observed outcome Y , so it mimics the potential outcome Y (∞) had the treatment never been initiated. We provide the formal statement as proved in Lok and DeGruttola (2012) .
where by convention, E · | A −1 = 0, A 0 , L 0 = E · | A 0 , L 0 .
We can not fit the SNMMs by regression models pooled over time, because they involve the unobserved potential outcomes. For parameter identification, we require the assumption of no unmeasured confounding 1992) .
Assumption 3 (No unmeasured confounding)
where ⊥ ⊥ means "is (conditionally) independent of " (Dawid; .
Assumption 3 holds if (A m−1 , L m ) contains all prognostic factors for Y (∞) that affect the treatment decision at time t m for 0 ≤ m ≤ K. Under this assumption, the observational study can be conceptualized as a sequentially randomized experiment.
Proposition 1 implies that under Assumption 3, for 0 ≤ m ≤ K,
see, e.g., Robins et al. (1992) , Lok et al. (2004) and Lok and DeGruttola (2012) . Equation (3) poses restrictions for the likelihood function for the observed data.
Semiparametric efficiency theory
The semiparametric model is characterized by the discrete-time SNMM (1) and restriction (3), where the parameter of primary interest is ψ * . We first present the general semiparametric efficiency theory. Suppose the data consist of n independent and identically distributed random variables F 1 , . . . , F n . We consider regular asymptotically linear (RAL) estimators ψ n for ψ * as
where P n denotes the empirical mean; i.e., P n Φ(F ) = n −1 n i=1 Φ(F i ), Φ(F ) is called the influence function of ψ n , with mean zero and finite and non-singular variance. Because ψ * is p-dimensional, Φ(F ) is also p-dimensional. From (4), the asymptotic variance of n 1/2 ( ψ n − ψ * ) is equal to the variance of its influence function. As a result, to construct the efficient RAL estimator, it suffices to find the influence function with the smallest variance.
To do this, we take a geometric approach of Bickel et al. (1993) . Consider the Hilbert space H of all p-dimensional, mean-zero finite variance measurable functions of F , denoted by h(F ), equipped with the covariance inner product < h 1 , h 2 >= E {h 1 (F ) T h 2 (F )} and the norm ||h|| = E {h(F ) T h(F )} 1/2 < ∞. Bickel et al. (1993) stated that influence functions for RAL estimators lie in the orthogonal complement of the nuisance tangent space in H. To motive the concept of the nuisance tangent space for a semiparametric model, we first consider a fully parametric model f (F ; ψ, θ), where ψ is a p-dimensional parameter of interest, and θ is an q-dimensional nuisance parameter. The score vectors of ψ and θ are S ψ (F ) = ∂ log f (F ; ψ, θ * )/∂ψ and S θ (F ) = ∂ log f (F ; ψ * , θ)/∂θ, both evaluated at the true values (ψ * , θ * ), respectively. For a parametric model, the nuisance tangent space Λ is the linear space in H spanned by the q-dimensional nuisance score vector S θ (F ). For semiparametric models, where the nuisance parameter is infinite-dimensional, the nuisance tangent space Λ is defined as the mean squared closure of all parametric sub-model nuisance tangent spaces. The efficient score S eff (F ) for the semiparametric model is the projection of S ψ onto the orthogonal complementary space of the nuisance tangent space Λ ⊥ ; i.e., S eff (F ) = S ψ | Λ ⊥ , where is the projection operator in the Hilbert space. The efficient influence
which achieves the semiparametric efficiency bound (Bickel et al.; 1993) . From this geometric point of view, to derive efficient semiparametric estimators for ψ * , it suffices to find the efficient score S eff (F ).
Influence functions
The key step is to characterize the space where the influence functions of RAL estimators belong to, i.e., the orthogonal complementary space of the nuisance tangent space Λ ⊥ . Following Robins (1994) , Theorem 2 characterizes all influence functions of RAL estimators for ψ * .
Proposition 2 For the semiparametric model characterized by the discrete-time SNMM (1) and restriction (3), the influence function space for ψ * is
indexed by c. To make the notation accurate, the abbreviation c in G(ψ; F, c) means c(V m ).
We now make a working assumption, which extends restriction (3) and allows us to derive an analytical expression of the semiparametric efficient score of ψ * .
Assumption 4 (Homoscedasticity
Proposition 3 (Discrete-time semiparametric efficient score) For the semiparametric model characterized by the discrete-time SNMM (1) and restriction (3), suppose further that Assumption 4 holds, the semiparametric efficient score of ψ * is
where
and dur(t m ) is the observed treatment duration from t m to τ .
The semiparametric efficiency theory of the discrete-time SNMM can be found in Robins (1994) . We have derived a detailed proof, which is available by the request for the interested readers.
3 SNMMs in continuous-time processes
Setup, models, and assumptions
We now extend discrete-time SNMMs in Section 2 to continuous-time SNMMs. We assume that the variables can change their values at any real time between 0 and τ . We assume that there is no censoring before τ until Section 3.4. Let L t be the multidimensional covariate process. Let A t be the binary treatment process. Define Y (t) as the potential outcome had the subject initiated the treatment at t, and define Y (∞) as the potential outcome had the subject never initiated the treatment before τ . Let Y be the continuous outcome measured at the end of the study τ . For the regulation purpose, we assume that the processes are Càdlàg processes, i.e., the processes are right continuous with left limits. Let V t = (A t− , L t ) be the combined covariate and treatment process, where A t− is the available treatment information right before t. We use the overline notation to denote a variable's history; e.g., A t = {A u : 0 ≤ u ≤ t}. Finally, the subject's full record is
We assume the continuous-time SNMM as follows.
i.e., γ t (L t ; ψ) with ψ ∈R p is a correctly specified model for γ t (L t ) with the true parameter value ψ * . Moreover,
In Model (6), ψ * is the treatment effect rate for the outcome. We also make an assumption that given (L t , T ≥ t), the treatment effect only changes the location of the distribution of the outcome but not on the other aspects of the distribution such as the variance. This assumption is weaker than the deterministic relationship assumption of Zhang et al. (2011) . In this case, for two subjects with the same treatment and covariate history, the subject with a larger Y must have a larger Y (∞) , the so-called rank preservation. The rank preservation may be restrictive in certain scenarios. Under our assumption, we relax this restriction by impose a distributional assumption.
We also assume that a correctly specified treatment effect model is
To link the observed outcome to the potential outcomes, we assume that
To identify the parameters in the continuous-time SNMM, we require the assumption of no unmeasured confounding (Yang, Tsiatis and Blazing; .
Assumption 6 (No unmeasured confounding) The hazard of treatment initiation is
Assumption 6 implies that λ T (t | F ) depends only on the past treatment and covariate history V t but not on the future observations and potential outcomes. The treatment process A t can also be represented in terms of the counting process N T (t) and the at-risk process Y T (t) of observing treatment initiation. Let σ(V t ) be the σ-field generated by V t , and let σ(V t ) be the σ-field generated by ∪ u≤t σ(V u ). Under the standard regularity conditions for the counting process, ) in the sense that it has the same distribution as Y (∞) given V t , Assumption 6 also implies that the jumping rate of N T (t) at t does not depend on H(ψ * ), given V t ; namely,
as shown in the Appendix. Therefore, under the standard regularity conditions, M T (t) is a martingale with respect to the filtration σ{V t , H(ψ * )}. Lok (2008) imposed this martingale condition to formulate the no unmeasured confounding assumption for the treatment process.
Semiparametric efficiency
We establish the semiparametric efficiency theory for the continuous-time SNMMs. We defer all proofs to the Appendix.
Theorem 1 Consider the semiparametric model defined by the continuous-time SNMM (6) and Assumption 6, the influence function space for ψ * is
The semiparametric efficiency score for
Based on Theorem 2, we derive the semiparametric efficient score for ψ * in the continuous-time SNMMs.
Theorem 3 (Continuous-time semiparametric efficient score) Consider the semiparametric model defined by the continuous-time SNMM (6) and Assumption 6, the semiparametric efficient score of ψ * is
where G(ψ; F, c) is defined in (10), and
To illustrate the theorem, we provide the explicit expression of the semiparametric efficient score using an example.
Example 1 Consider γ t (L t ; ψ * ) given by (7) . The mimicking potential outcome of
and therefore,
By (12) and (13), the semiparametric efficient score of
Remark 1 The proposed continuous-time semiparametric efficient score contains the discrete-time semiparametric efficient score as a special case. If the processes take observations at discrete times
Therefore, the continuous-time semiparametric efficient score (12) reduces to the discrete-time semiparametric efficient score (5).
Double robust estimators
We now construct a general class of estimators based on the estimating function G(ψ * ; F, c). Because E{G(ψ * ; F, c)} = 0, we obtain the estimator of ψ * by solving
In particular, (15) with c eff provides the semiparametric efficient estimator of ψ * .
In (15), we assume that the treatment process and E H(ψ * ) | V u , T ≥ u are known. In practice, they are often unknown and must be modeled and estimated from the data. We posit a proportional hazards model with time-dependent covariates for the treatment process; i.e.,
where λ T,0 (t) is the unknown baseline hazard function, W T (t, V t ) is a pre-specified function of t and V t , and α is a vector of unknown parameters. Under Assumption 6, we can estimate the unknown function λ T,0 (t) and α from the standard software such as "coxph" in R (R Development Core Team, 2012) . To estimate α, fit the time-dependent proportional hazards model to the data
. . , n} treating the treatment initiation as the failure event. Once we obtain α, we can estimate the cumulative baseline hazard, λ T,0 (t)dt by
.
We also posit a working model E H(ψ * ) | V u , T ≥ u; β , such as a linear regression model, where β is a vector of unknown parameters.
The estimating equation for ψ * achieves the double robustness or double protection (Rotnitzky and Vansteelandt 2015) .
Theorem 4 (Double robustness) Under Assumption 6 and Model (7), the estimating equation (15) for ψ * is unbiased of zero if either the model for the treatment process is correctly specified, or the potential outcome mean model E H(ψ * ) | V u , T ≥ u; β is correctly specified, but not necessarily both.
The choice of c does not affect the double robustness but the efficiency of the resulting estimator. For efficiency consideration, we consider c eff in (13). The resulting estimator solving the empirical version of the estimating equation with c eff is locally efficient, in the sense that it achieves the semiparametric efficiency bound if the working models for the treatment process and the potential outcome mean are correctly specified. Because c eff depends on the unknown distribution, we require additional models to approximate c eff . For example, to approximate c eff in (14), we require models
we consider the following options: (i) we assume var{H(ψ * ) | V u , T ≥ u} to be a constant, and (ii) based on some preliminary estimator ψ p , we approximate var{H(ψ * ) | V u , T ≥ u} by the sample variance of H( ψ p ) among subjects with T ≥ u. We assess the two options in the simulation study. Although option (ii) provides some slight efficiency gain in estimation, we recommend option (i) for ease of implementation. Option (i) is common in the generalized estimating equation framework. From here on, we use this option for c and suppress the dependence on c for estimating functions.
Censoring
In most longitudinal observational studies, subjects may drop out the study prematurely before the end of study, which renders the data censored at the time of drop out. If the censoring mechanism depends on time-varying prognostic factors, e.g. sicker patients drop out of the study with a higher probability than healthier patients, the patients remaining in the study constitute a biased sample of the full population. We now introduce C to be the time to censoring. Let X = min(C, τ ) be time to censoring or the end of the study, whichever came first. Let δ C = I(C ≥ τ ) be the indicator of not censoring before τ . The observed data is O = (X, V X , δ C , δ C Y ).
In the presence of censoring, estimating equation (15) is not feasible. We consider inverse probability of censoring weighting (IPCW; 1993) . We assume a dependent censoring mechanism as follows.
Assumption 7 (Dependent censoring) The hazard of censoring is
Assumption 7 states that λ C (t | F, T > t) depends only on the past treatment and covariate history until t, but not on the future variables and potential outcomes. This assumption holds if the set of historical covariates contains all prognostic factors for the outcome that affect the possibility of loss to follow up at t. Under this assumption, the missing data due to censoring are missing at random 1976) .
We discuss the implication of Assumption 7 on estimation of the treatment process model. Under Assumption 7, (8) is equal to P (t ≤ T < t + h | V t , T > t, C ≥ t). Redefining T to be the time to treatment initiation, or censoring, or the end of the study, whichever came first, (8) can be estimated by conditioning on T ≥ t with the new definition of T.
From
which is the probability of the subject not being censored before t. For regularity, we impose a positivity condition for
Assumption 8 (Positivity) There exists a constant δ such that with probability one,
The main idea underlying IPCW is to re-distribute the weights of censored subjects to the similar uncensored subjects. Following Rotnitzky et al. (2007) , we obtain the IPCW estimator ψ as the solution to the following equation:
As shown in the Appendix, under Assumptions 7 and 8, (18) is an unbiased estimating equation for ψ * .
In (18), we assume that λ
is often unknown and must be modeled and estimated from the data. To facilitate estimation, we posit a proportional hazards model for the censoring process with time-dependent covariates; i.e.,
where λ C,0 (t) is the unknown baseline hazard function of censoring, W C (t, V t ) is a pre-specified function of t and V t , and η is a vector of unknown parameters. Under Assumption 7, we can estimate the unknown function λ C,0 (t) and α from the standard software such as "coxph" in R. To estimate η, fit the time-dependent proportional hazards model to the data {(V X i ,i , X i , δ C,i ) : i = 1, . . . , n} treating the censoring as the failure event. Once we obtain η, we can estimate λ C,0 (t)dt by
where N C (t) = I(C ≤ t, δ C = 0) and Y C (t) = I(C ≥ t) are the counting process and the at-risk process of observing censoring. Then, we estimate K C t | V t by
The proposed estimator depends on estimation of nuisance parameters. To summarize, we have the following nuisance models: (i) E{H(ψ * ) | V u , T ≥ u; β} indexed by β; (ii) the proportional hazards model for the treatment process (16), indexed by M T ; and (iii) the proportional hazards model for the censoring process (19), indexed by K C . β, M T , and K C are the estimates of β, M T , and K C under the specified parametric and semiparametric models. Denote the probability limits of β, M T , and K C as β * , M * T , and K * C . If the outcome model is correctly specified,
if the model for the treatment process is correctly specified, M * T = M T ; and if the model for the censoring process is correctly specified, K * C = K C . To reflect that the estimating function depends on the nuisance parameters, we define
Then, we obtain the estimator ψ of ψ by solving
restricted to subjects with T ≥ u. We note that ψ retains the double robustness in that under a correct model specification for the censoring, ψ is consistent if either the potential outcome mean model or the model for the treatment process is correctly specified. It is important to characterize the asymptotic properties of ψ under the double robustness condition, which allows for doubly robust inference of ψ * .
Asymptotic property and variance estimation
We first introduce additional notation. Let P denote the true data generating distribution of F , and for any g(F ), let P {g(F )} = g(f )dP (f ). We define Similar to Yang and Lok (2016) , we now impose the regularity conditions from the empirical process literature (van der Vaart and Wellner; 1996) .
Assumption 9 (i) Φ(ψ, β, M T , K C ; F ) and ∂Φ(ψ, β, M T , K C ; F )/∂ψ are P -Donsker classes; i.e.,
and that J 1 ( β), J 2 ( M T ), and J 3 ( K C ) are regular asymptotically linear with influence functions
respectively. We first discuss the implications of these conditions. First, the P -Donsker class condition requires the submodels for the nuisance parameters are not too complex. Under Assumption 8 for the censoring process, Assumption 9 (i) is a standard condition for the empirical processes. We refer the interested readers to Section 4.2 of Kennedy (2016) for a through discussion of Donsker classes of functions. Second, Assumption 9 (ii) states that β, M T , and K C have probability limits β * , M * T , and K C , and that
and
are o p (n −1/2 ). (21) and (22) hold if either the potential outcome mean model or the model for the treatment process is correctly specified. This is the key to achieving the double robustness. There are different approaches to satisfy (21) and (22). We comment on this point in Remark 2. Third, Assumption 9 (iv) holds for smooth functionals of parametric or semiparametric efficient estimators under specified models. Therefore, this assumption would hold under mild regularity conditions if β, M T , and K C are the parametric and semiparametric maximum likelihood estimators of β * ,M * T , and K * C under specified models. We present the asymptotic properties of the proposed estimator ψ solving equation (20).
Theorem 5 Under Assumptions 8 and 9, n 1/2 ψ − ψ * is consistent and asymptotically linear with the influence function
where A(ψ * , β * , M * T , K * C ) is defined in Assumption 9 (iii), and
Theorem 5 allows for doubly robust variance estimation of ψ. If the nuisance models are correctly specified, we characterize the influence function Φ(ψ * , β * , M * T , K * C ; F ) in the Appendix. Then, we obtain the variance estimator of ψ as the empirical variance of the individual influence function with the unknown parameters replaced by their estimates. Under the double robustness condition if one of the nuisance models is misspecified, it is difficult to characterize the influence function Φ(ψ * , β * , M * T , K * C ; F ). We suggest estimating the asymptotic variance of ψ by nonparametric bootstrap of Efron (1979) . The consistency of the bootstrap is guaranteed by the regularity and asymptotic properties of ψ in Theorem 5.
Remark 2
The key assumption to achieving the double robustness is (21) and (22). Another way to achieve the double robustness is if we have
, so that their product term is asymptotically negligible. This holds if both E H(ψ * ) | V u , T ≥ u and M T (u | V u ) use correctly specified parametric models, but it can also hold for semipar-or nonparametric estimators, such as single index models, generalized additive models (Horowitz; 2009), Lasso estimators , and machine learning methods such as random forests 2016) .
Simulation study
We now evaluate the finite-sample performance of the proposed estimator on simulated datasets with two objectives. First, we assess the double robustness and efficiency of the proposed estimator based on the semiparametric efficiency score, compared to some preliminary estimator. Second, to demonstrate the impact of data gridization as commonly done in practice, we include the g-estimator applied to the pre-processed data with different grid sizes.
We simulate 1, 000 datasets under two settings with and without censoring. In Setting I, we generate two covariates, one time-independent (L T I ) and one time-dependent (L T D ). The timeindependent covariate is generated from a Bernoulli distribution with mean equal to 0.55. The timedependent covariate is a 1 × 4 row vector generated from a multivariate normal distribution with mean equal to (0, 0, 0, 0) and covariance equal to 0.7 |i−j| fori, j = 1, . . . , 4. This vector represents the value of L T D,t at t 1 = 0, t 2 = 0.5, t 3 = 1, and t 4 = 1.5. We assume that the time-dependent variable remains constant between measurements. The maximum follow up time is τ = 2.
We generate the time to treatment initiation T with the hazard rate λ T (t | V t ) = λ T,0 (t) exp( α * 1 L T I + α * 2 L T D,t ) with λ T,0 (t) = λ T,0 = 0.4, α * 1 = 0.15, and α * 2 = 0.8. We generate T according to the time-dependent model sequentially. This is because the hazard of treatment initiation in the time interval from t 1 = 0 to t 2 = 0.5 differs from the hazard of treatment initiation in the next interval and so on. The algorithm for constructing T for each simulated subject is as follows:
Algorithm 1 for generating T according to a time-dependent proportional hazards model
Step 1. Set k = 1.
Step 2. Generate a temporary time to treatment initiation, T temp,k , compatible with the hazard function for the time interval [t k , t k+1 ), using the method of Bender et al. (2005) ; namely,
else if T temp,k is not contained within the interval [0, t k+1 − t k ), increase k by 1 and move to the beginning of Step 2.
We let Y (∞) = L T D,τ be the potential outcome had the subject never initiated the treatment before τ . The observed outcome is Y = Y (∞) +γ T,ψ (V T ), where γ(V u ; ψ * ) = (ψ * 1 +ψ * 2 u)(τ −u)I(u ≤ τ ) with ψ * 1 = 1.5 and ψ * 2 = −0.5. We consider the following estimators:
where • The proposed estimator ψ cont,1 solving
i.e., the corresponding estimating function is the efficient score (12) with var{H(ψ) | V u , T ≥ u} replaced by a constant. In (25), we obtain E{H( ψ p ) | V u , T ≥ u; β} by a linear regression model of H( ψ p ) against u, L T I , L T D,u , and all interactions of these terms, restricted to subjects with T ≥ u.
• The proposed estimator ψ cont,2 solving
i.e., the corresponding estimating function is the efficient score (12). In (26), we obtain var{H(ψ * ) | V u , T ≥ u} by the empirical variance of H( ψ p ) − E{H( ψ p ) | V u , T ≥ u; β}, restricted to subjects with T ≥ u.
• The g-estimator in Section 2 applied to the data after gridization with K + 1 equally-spaced time points from 0 to τ . For m ≥ 1, at the mth time point t m , L m is the the average of L t from t m−1 ≤ t ≤ t m , A m is the indicator of whether the treatment is initiated before t m , and the time to treatment initiation T is t m if A m = 1 and A m−1 = 0. The g-estimator of ψ * solves the estimating equation based on (5), where the nuisance models are estimated similar to what are used for ψ cont,1 and ψ cont,2 but with the re-shaped data. We consider two g-estimators: ψ g,1 uses 5 time points and ψ g,2 uses 10 time points.
To investigate the double robustness, we consider two models for estimating M T : Scenario (i) the correctly specified proportional hazards model with both time-independent and time-dependent covariates; and Scenario (ii) the misspecified proportional hazards model with only time-independent covariate. For all estimators, we use the bootstrap for variance estimation with the bootstrap size 100. Table 1 shows the Monte Carlo bias, standard error, root mean squared errors of the estimators and the empirical coverage rate of the 95% confidence intervals over the simulated datasets for the sample size n = 1, 000 and n = 2, 000, respectively. Under Scenario (i) when the model for the Scenario (i) with a correctly specified model for M T Preliminary: ψ p -0.1 0.4 5.2 9.5 5.2 9.5 95.1 95.0 Proposed 1: ψ cont,1 -0.1 0.5 5.2 9.1 5.2 9.1 94.9 95.5 1000 Proposed 2: ψ cont,2 -0.1 0.5 5.1 9.0 5.2 9.0 95.1 95.5 g-estimator 1: ψ g,1 36.4 8.5 10.3 14.6 37.7 16.5 5.6 90.1 g-estimator 2: ψ g,2 13.6 3.9 6.4 10.5 15.0 11.1 43.3 93.1 Preliminary: ψ p -0.1 0.1 3.6 6.4 3.7 6.7 94.8 95.5 Proposed 1: ψ cont,1 -0.1 0.1 3.6 6.1 3.7 6.4 94.7 95.9 2000 Proposed 2: ψ cont,2 -0.1 0.1 3.6 6.1 3.7 6.3 94.5 95.5 g-estimator 1: ψ g,1 37.5 7. 9.2 20.7 18.9 17.4 59.1 g-estimator 2: ψ g,2 11.0 10.5 4.4 6.9 11.8 12.7 32.1 70.8 time to treatment initiation is correctly specified, ψ p , ψ cont,1 , and ψ cont,2 show small biases. As a result, the coverage rates are close to the nominal level. Under Scenario (ii) when the model for the time to treatment initiation is misspecified, ψ p shows larger biases, and ψ cont,1 , and ψ cont,2 still show small biases. Moreover, as the sample size increases, the mean square errors of ψ cont,1 , and ψ cont,2 decrease. This confirms the double robustness of the proposed estimators. The two proposed estimators have similar performance. The proposed estimator ψ cont,2 with var{H(ψ * ) | V u , T ≥ u} produces slightly smaller standard errors and root mean squared errors; however, this reduction is not large. In practice, we recommend ψ cont,1 because of its simpler implementation than ψ cont,2 . We note large biases in the g-estimators, which illustrates the consequence of data pre-processing for the subsequent analysis. With the grid size increase, the bias becomes smaller.
In Setting II, we further generate the time to censoring C with the hazard rate λ C (t | V t ) = λ C,0 (t) exp(η * 1 L T I + η * 2 L T D,t ), with λ C,0 (t) = 0.2, and η * 1 = η * 2 = 0.2, following the same algorithm for generating the time to treatment initiation. In the presence of censoring, we consider the five estimators considered in Setting I with weighting; that is, the corresponding estimating functions for (24)-(26) are now weighted by δ C / K C (τ | V τ ), and we obtain K C (τ | V τ ) under the true model of time to censoring. Table 2 shows the simulation results in Setting II. The same discussion as in Table 2 : Simulation results in Setting II with censoring based on 1, 000 simulated datasets: the Monte Carlo bias, standard error, root mean square error of the estimators, and coverage rate of 95% confidence intervals.
Bias
Scenario (i) with a correctly specified model for M T Preliminary: ψ p 0.1 -0.1 6.1 10.9 6.2 11.3 95.7 96.3 Proposed 1: ψ cont,1 0.1 0.0 6.1 10.4 6.2 10.8 95.3 96.6 1000 Proposed 2: ψ cont,2 0.1 -0.1 6.0 10.3 6.2 10.6 95.6 96. Setting I applies.
Application
We applied our estimator to the observational Acute Infection and Early Disease Research Program (AIEDRP) database consisting of 1762 HIV-positive patients diagnosed during acute and early infection. Lok and DeGruttola (2012) investigated how the time to initiation of highly active antiretroviral treatment (HAART) after HIV infection predicts the effect of one year of treatment based on this database. Lok (2016, 2017) developed a goodness-of-fit procedure and a sensitivity analysis to the departure of the no unmeasured confounding assumption. Their analyses showed that HAART is beneficial for HIV-positive patients in acute and early infection, with a possible increased beneficial effect of earlier HAART initiation. All these methods were based on the monthly data after gridization. However, the observations from the original data are collected by user-initiated visits and are irregularly spaced. We aim to estimate the averaged causal relationship between the time to HAART initiation and the mean CD4 counts at year 2 after HIV infection based on the original data. The outcome variable Y is the CD4 count measured by the end of year 2, with the quantile range from 443 cells/mm 3 to 794 cells/mm 3 . In this database, 45% of patients dropped out of the study before year 2, rendering 969 patients with complete observations. Among those patients, 36% of patients did not initiate the treatment before year 2. The observed time to treatment initiation ranges from 12 days to 282 days. The covariates X include age at infection, gender, race, injection drug ever/never, CD4 count, and log viral load.
We assume the true treatment effect model to be γ(V u ; ψ) = (ψ 1 + ψ 2 t)(τ − t)I(t ≤ τ ). We consider the preliminary estimator ψ p , the proposed estimators ψ cont,1 and ψ cont,2 considered in Section 5. In the estimation procedure, we fit the models for time to treatment initiation and time to censoring by proportional hazards models with both time-independent and time-varying confounders, and we fit the outcome models by linear regression models, adjusting for a rich set of covariates based on the HIV literature and clinical knowledge. See the Appendix for details. For all estimators, we use the bootstrap for variance estimation and the 95% confidence interval with the bootstrap size 100. Table 3 shows the results for the effect of HAART on the CD4 count at year 2. We note only slight differences in the point estimates between our estimators. The preliminary estimator has slight larger standard error than the two proposed estimators. Based on our results, on average, initiation of HAART at the time of infection can increase CD4 counts at year 2 by 14.3 × 24 ≈ 343 cells/mm 3 ; while initiation of HAART 3 months after the time of infection can increase CD4 counts at year 2 by (14.3 − 1.01 × 3) × (24 − 3) ≈ 237 cells/mm 3 .
Discussion
We have developed a new estimation framework to evaluate treatment effects that accommodates irregularly-spaced observations in longitudinal observational studies. There are several directions for future work of extending the continuous-time SNMMs framework.
Other types of outcome
We consider a general specification of the SNMM as
where g(·) is a pre-specified link function; see Vansteelandt et al. (2014) . The SNMM (27) accommodates different types of outcome. For the continuous outcome, g(·) can be an identity link as we specified in this article. For the binary outcome, g(·) can be logit link g(x) = logit(x) = log{x/(1 − x)},
and (27) specifies an effect model γ t (L t ; ψ * ) for odds
where odds(Y = 1 | X) = P (Y = 1 | X)/P (Y = 0 | X) for random variables X and Y . In this case, H(ψ * ) can be constructed as
The semiparametric efficiency theory for this setting can then be developed similarly. For a time to event outcome, we can consider the structural nested failure time models (Robins and Tsiatis; 1991; 1992; Yang, Pieper and Cools; .
Effect modification
Effect modification occurs when the magnitude of the treatment effect varies as a function of other observed covariates. We have focused on a pre-specified treatment effect model where the only effect modifier is time to treatment initiation. It is also important to study how the treatment effect varies in different subpopulations, which can facilitate optimal treatment decision in precision medicine (Murphy; 2003) . Assume a general treatment model γ
We would like to develop a variable selection procedure for identifying effect modifiers in such setup. Note that we can have a larger number of estimating functions than the number of parameters, the selection of effect modifiers falls into the recent work of Chang et al. (2018) on high-dimensional statistical inferences with over-identification.
Sensitivity analysis to no unmeasured confounders
The key assumption we rely on to identify the causal parameters in the SNMMs is the no unmeasured confounding assumption. However, this assumption is not verifiable based on the observed data. Therefore, it is important to assess the impact of possible uncontrolled confounding. Yang and Lok (2017) proposed a modified g-estimator of the discrete-time SNMMs assuming a bias function quantifying the impact of unmeasured confounding on the average potential outcome, i.e., g(L m ) = E{Y (∞) | A m−1 = 0, A m = 1, L m } − E{Y (∞) | A m−1 = 0, A m = 0, L m }. Such a bias function is not directly applicable to the continuous-time SNMMs because the conditioning sets (A m−1 = 0, A m = 1, L m ) and (A m−1 = 0, A m = 0, L m ) are not well defined for the continuous-time process. It would be important to develop a sensitivity analysis for the continuous-time SNMMs to unmeasured confounding.
where the third equality follows because M k=1 f A v k | A v k−1 = 0, L v k ; θ 3 can be equivalently expressed as the likelihood based on the data (T, Γ) given V T , and θ = (θ 1 , θ 2 , θ 3 ) is a vector of infinite-dimensional nuisance parameters given nonparametric models.
Let Λ k be the nuisance tangent space for θ k , for k = 1, 2, 3. We now characterize Λ k . Assuming f {H(ψ * ); θ 1 } and M k=1 f L v k | A v k−1 = 0, L v k−1 , H(ψ * ); θ 2 are nonparametric, it follows from Section 4.4 of Tsiatis (2006) that the tangent space regarding θ 1 is
and the tangent space of θ 2 is
it follows from Tsiatis (2006) that the tangent space of θ 3 is
Then, Λ = Λ 1 ⊕ Λ 2 ⊕ Λ 3 , where ⊕ denotes a direct sum. This is because θ 1 , θ 2 , and θ 3 separate out in the likelihood function and therefore Λ 1 , Λ 2 and Λ 3 are mutually orthogonal.
To characterize Λ ⊥ , we use the following trick. Let
Because the tangent space Λ 1 ⊕ Λ 2 ⊕ Λ * 3 is that for a nonparametric model; i.e., a model that allows for all densities of O, and because the tangent space for a nonparametric model is the entire Hilbert space, we obtain H = Λ 1 ⊕ Λ 2 ⊕ Λ * 3 . Because Λ ⊥ must be orthogonal to Λ 1 ⊕ Λ 2 , it means that Λ ⊥ consists of all elements of Λ * 3 that are orthogonal to Λ 3 . It then suffices to find the projection of all
Therefore, we have
for any h u (V u ).
It is important to note that by Assumption 6, M T (t) is a martingale with respect to the filtration σ{V t , H(ψ * )}. If P 1 (u) and P 2 (u) are locally bounded σ{V t , H(ψ * )}-predictable processes, then we have the following useful result:
Therefore,
A3 Proof of Theorem 2
For any B = B(F ), let
To show B | Λ ⊥ = G, it is easy to see that G ∈ Λ ⊥ , so the remaining is to show that B − G ∈ Λ. Toward this end, we show that for anyG
We now verify E(BG) = E(GG) by the following calculation.
Firstly, by (A4), we calculate
Secondly, we calculate
where the last equality follows because
Therefore, by (A6) and (A7), E(BG) = E(GG) for anyG ∈ Λ ⊥ , proving (11).
A4 Proof of Theorem 3
The semiparametric efficient score is S * eff (ψ * ) = S ψ | Λ ⊥ . By Theorem 2, we have
where the last equality follows by using the generalized information equality: becauseḢ u (ψ * ) =
Ignoring the negative sign, the result in Theorem 3 follow.
A5 Proof of Theorem 4
We show that E{G(ψ * ; F, c)} = 0 in two cases. First, if λ T (t | V t ) is correctly specified, under Assumption 6, M T (t) is a martingale with respect to the filtration σ{V t ,
is not necessarily correctly specified, let λ * T (t | V t ) be the probability limit of the possibly misspecified model. We obtain
where zero in (A8) follows because dM A6 Proof of the unbiasedness of (18)
To show (18) is an unbiased estimating equation, it suffices to show that
Toward that end, by the iterative expectation, we have
where the third equality follows by Assumption 7.
A7 Proof of Theorem 5
We assume that the model for the censoring process is correctly specified, either the potential outcome mean model or the model for the treatment process is correctly specified.
Taylor expansion of P n Φ( ψ, β, M T , K C ; F ) = 0 around ψ * leads to
where ψ is on the line segment between ψ and ψ * . Under Assumption 9 (i) and (ii),
We then have
To evaluate (A10) further, P n Φ(ψ * , β, M T , K C ; F ) = (P n − P )Φ(ψ * , β, M T , K C ; F ) + P Φ(ψ * , β, M T , K C ; F ) − Φ(ψ * , β * , M * T , K * C ; F ) + P Φ(ψ * , β * , M * T , K * C ; F ). (A11)
By Assumption 9 (i) and (ii), the first term in (A5) becomes (P n − P )Φ(ψ * , β, M T , K C ; F ) = (P n − P )Φ(ψ * , β * , M * T , K * C ; F ) + o p (n −1/2 ) = P n Φ(ψ * , β * , M * T , K * C ; F ) + o p (n −1/2 ).
By Assumption 9 (iv), the second term in (A5) becomes P Φ(ψ * , β, M T , K C ; F ) − Φ(ψ * , β * , M * T , K * C ; F ) = J( β, M T , K C ) − J(β * , M * T , K * C ) + o p (n −1/2 ) = J 1 ( β) − J 1 (β 1 ) + J 2 ( M T ) − J 2 (M 1 T ) + J 3 ( K C ) − J 3 (M 1 C ) + o p (n −1/2 ) = P n {Φ 1 (ψ * , β * , M * T , K * C ; F ) + Φ 2 (ψ * , β * , M * T , K * C ; F ) + Φ 3 (ψ * , β * , M * T , K * C ; F )} . (A13)
Based on the double robustness, the third term in (A5) becomes P Φ(ψ * , β * , M * T , K * C ; F ) = 0.
Combining (A12)-(A14) with (A11), P n Φ(ψ * , β, M T , K C ; F ) = P n { B(ψ * , β * , M * T , K * C ; F )}, where B(ψ * , β * , M * T , K * C ; F ) = Φ(ψ * , β * , M * T , K * C ; F ) + Φ 1 (ψ * , β * , M * T , K * C ; F ) +Φ 2 (ψ * , β * , M * T , K * C ; F ) + Φ 3 (ψ * , β * , M * T , K * C ; F ).
As a result, n 1/2 ( ψ − ψ * ) = n 1/2 P n Φ(ψ * , β * , K * V , K * C ; F ) + o p (1),
where Φ(ψ * , β * , M * T , K * C ; F ) = {A(ψ * , β * , M * T , K * C )} −1 B(ψ * , β * , M * T , K * C ; F ). We now consider the case when all nuisance models are correctly specified, i.e., E{H(ψ * ) | V u , T ≥ u; β * } = E{H(ψ * ) | V u , T ≥ u}, M * T = M T , and K * C = K C . Define the score functions: S β := S β {H(ψ * ), V u , T ≥ u}. Then, the tangent space for β is Λ 1 = {S β ∈ R p : E(S β | V u , T ≥ u) = 0}. Following Tsiatis (2006) , the nuisance tangent space for the proportional hazards model (16) is
The nuisance tangent space for the proportional hazards model (19) is
Assuming that the treatment process and the censoring process can not jump at the same time point, Λ 1 , Λ 2 , and Λ 3 are mutually orthogonal to each other. Therefore, the nuisance tangent space for β and the proportional hazards models (16) and (19) is Λ = Λ 1 ⊕ Λ 2 ⊕ Λ 3 . The influence function for ψ is
Moreover, if the nuisance models including the models for the censoring process and the treatment process and the potential outcome mean model are correctly specified, (23) becomes -0.02 0.004 0.00 *** white non-hispanic 0.12 0.066 0.07 . 0.02 0.077 0.77 injdrug -0.50 0.180 0.01 ** 0.74 0.156 0.00 *** CD4 1/2 u -0.06 0.007 0.00 *** -0.03 0.007 0.00 *** lvl u -0.14 0.013 0.00 *** 0.04 0.016 0.02 * days from last visit u -0.03 0.002 0.00 *** -0.01 0.001 0.00 *** first visit u -3.06 0.111 0.00 *** -1.24 0.231 0.00 *** second visit u -0.04 0.081 0.61 0.68 0.178 0.00 *** Treated u ----0.15 0.102 0.15 Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.'
A8 Nuisance models and fitting results in the Application
We describe the nuisance models and fitting results for the AIEDRP database.
• The censoring model (K C ) is a time-dependent proportional hazards model adjusting for age at infection (age), male, white non-Hispanic race (race), injection drug ever/never (injdrug), square root of current CD4 count (CD4 1/2 u ), log viral load (lvl u ), and whether a patient had initiated HAART (Treated u ).
• The time to treatment initiation model (M T ) is a time-dependent proportional hazards model adjusting for age, male, race, injdrug, CD4 1/2 u , lvl u , number of days since the last visit (days from last visit u ), whether the visit is the first visit (first visit u ), whether the visit is the second visit (second visit u ).
• The outcome model E{H( ψ p ) | V u , T ≥ u; β} is a linear regression model where the covariates include age, male, race, injdrug, CD4 u , lvl u , CD4 Table 4 reports the fitted time-dependent proportional hazards models for the time to treatment initiation and the time to censoring. The results suggest that the covariates are important for predicting the time to treatment initiation and the time to censoring.
